|
|
|
|
| LEADER |
00000cam a2200000Ii 4500 |
| 001 |
EBSCO_ocn930144152 |
| 003 |
OCoLC |
| 005 |
20231017213018.0 |
| 006 |
m o d |
| 007 |
cr cnu---unuuu |
| 008 |
151123s2016 nyu ob 001 0 eng d |
| 040 |
|
|
|a N$T
|b eng
|e rda
|e pn
|c N$T
|d YDXCP
|d EBLCP
|d SNK
|d DKU
|d MHW
|d IGB
|d D6H
|d VTS
|d AGLDB
|d G3B
|d S8J
|d S9I
|d STF
|d M8D
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCO
|
| 019 |
|
|
|a 945735717
|a 948511234
|
| 020 |
|
|
|a 9781634838023
|q electronic bk.
|
| 020 |
|
|
|a 1634838025
|q electronic bk.
|
| 035 |
|
|
|a (OCoLC)930144152
|z (OCoLC)945735717
|z (OCoLC)948511234
|
| 050 |
|
4 |
|a RC667
|
| 072 |
|
7 |
|a HEA
|x 039000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 014000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 022000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 112000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 045000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 616.1
|2 23
|
| 049 |
|
|
|a UAMI
|
| 245 |
0 |
0 |
|a Horizons in world cardiovascular research.
|n Volume 9 /
|c edited by Eleanor H. Bennington.
|
| 264 |
|
1 |
|a New York :
|b Nova Science Publishers,
|c [2016]
|
| 264 |
|
4 |
|c ©2016
|
| 300 |
|
|
|a 1 online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 347 |
|
|
|a data file
|2 rda
|
| 490 |
1 |
|
|a Horizons in World Cardiovascular Research (NOT ON COVER)
|
| 588 |
0 |
|
|a Online resource; title from PDF title page (EBSCO, viewed November 23, 2015).
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 505 |
0 |
|
|a HORIZONS IN WORLD CARDIOVASCULAR RESEARCH VOLUME 9 ; HORIZONS IN WORLD CARDIOVASCULAR RESEARCH VOLUME 9 ; Library of Congress Cataloging-in-Publication Data; CONTENTS ; PREFACE; Chapter 1 NEWER ANTICOAGULANTS IN NON-VALVULAR ATRIAL FIBRILLATION; ABSTRACT; INTRODUCTION ; NON VITAMIN K ANTAGONIST ORAL ANTICOAGULANTS (NOACS) ; DABIGATRAN ; RIVAROXABAN ; APIXABAN ; DISCUSSION ; REFERENCES ; Chapter 2 GENDER AND PROGNOSIS IN CARDIOVASCULAR DISEASE; ABSTRACT ; INTRODUCTION ; OBJECTIVE ; METHODS ; RESULTS ; DISCUSSION ; CONCLUSION ; REFERENCES.
|
| 505 |
8 |
|
|a Chapter 3 CARDIOVASCULAR CONTROL VIA THE VESTIBULAR SYSTEM ABSTRACT ; INTRODUCTION ; CONTROL OF ARTERIAL PRESSURE WITH A CHANGE IN GRAVITY ; ARTERIAL PRESSURE CONTROL DURING POSTURAL CHANGES ; ORTHOSTATIC HYPOTENSION; CONCLUSION ; REFERENCES ; Chapter 4 INFLAMMATION AND THE ENDOTHELIUM: AN ALTERNATIVE VIEW; ABSTRACT ; INTRODUCTION ; THE IMPACT OF INFLAMMATION ON ENDOTHELIAL SIGNALING PROCESSES ; THE IMPACT OF TRANSCRIPTIONAL EXPRESSION CONTROL ON CARDIOVASCULAR FUNCTIONS DURING INFLAMMATION ; MODULATION OF ALTERNATIVE SPLICING UNDER INFLAMMATORY CONDITIONS IN CD.
|
| 505 |
8 |
|
|a THE IMPACT OF AS ON BIOLOGICAL FUNCTION OF CHEMOKINES AND THEIR RECEPTORSTHE INFLUENCE OF AS OF THE ENDOTHELIAL NITRIC OXIDE SYNTHASE ON BLOOD PRESSURE CONTROL; THE MODULATION OF TISSUE FACTOR-MEDIATED CARDIOVASCULAR FUNCTIONS BY AS ; THE ALTERNATIVE IMPACT OF PROTEIN ISOFORMS INVOLVED IN OTHER CARDIOVASCULAR FUNCTIONS ; THE INFLUENCE OF MIRNAS ON ENDOTHELIAL FUNCTIONS UNDER INFLAMMATORY CONDITIONS ; The Role of miRNAs in Blood Coagulation Control ; Regulation of Angiogenesis via miRNAs in the Cardiovascular System ; MiRNA-Mediated Regulation of Blood Pressure Control ; CONCLUSION.
|
| 505 |
8 |
|
|a ACKNOWLEDGMENTS REFERENCES ; Chapter 5 RENOVASCULAR HYPERTENSION: PATHOPHYSIOLOGY AND TREATMENT OPTIONS ; ABSTRACT; 1. EPIDEMIOLOGY AND PHYSIOPATHOLOGY; 2. DIAGNOSIS ; 2.1. Diagnostic Methods ; 2.1.1. Arterial Angiography ; 2.1.2. Duplex Ultrasound ; 2.1.3. Magnetic Resonance Angiography (MRA) ; 2.1.4. Computed Tomographic Angiography (CTA); 2.1.5. Captopril Renography (CR) ; 3. TREATMENT OF RENOVASCULAR HYPERTENSION ; 3.1. Medical Therapy ; 3.2. Percutaneous Interventions ; 3.3. Surgical Revascularization ; CONCLUSION ; REFERENCES; Chapter 6 NUTRITIONAL MODULATORS OF HYPERTENSION.
|
| 505 |
8 |
|
|a ABSTRACT INTRODUCTION ; PATHOPHYSIOLOGY OF HYPERTENSION ; FUNCTIONAL FOODS AND NUTRIENTS AGAINST BLOOD PRESSURE; Role of Probiotics in Hypertension ; Experiences with "Dash Diet" ; IMPACT OF OMEGA 3 FATTY ACIDS ON HYPERTENTION ; Sources of Omega-3 Fatty Acids ; Metabolism of Omega 3 Fatty Acids and Its Vascular Reactivity ; Pharmacological Characteristics of Omega 3 Fatty Acids ; Clinical Evidence of the Effect of Omega- 3 Fatty Acids on Blood Pressure ; Dietary Guidelines for Omega-3 Pufa ; IMPACT OF POTTASIUM, MAGNESIUM AND CALCIUM ON HYPERTENSION; Potassium; MAGNESIUM ; CALCIUM.
|
| 590 |
|
|
|a eBooks on EBSCOhost
|b EBSCO eBook Subscription Academic Collection - Worldwide
|
| 650 |
|
0 |
|a Cardiovascular system
|x Diseases.
|
| 650 |
|
2 |
|a Cardiovascular Diseases
|
| 650 |
|
6 |
|a Appareil cardiovasculaire
|x Maladies.
|
| 650 |
|
7 |
|a HEALTH & FITNESS / Diseases / General
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL / Clinical Medicine
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL / Diseases
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL / Evidence-Based Medicine
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL / Internal Medicine
|2 bisacsh
|
| 650 |
|
7 |
|a Cardiovascular system
|x Diseases
|2 fast
|
| 700 |
1 |
|
|a Bennington, Eleanor H.,
|e editor.
|
| 776 |
0 |
8 |
|i Print version:
|a Bennington, Eleanor H.
|t Horizons in World Cardiovascular Research. Volume 9.
|d Hauppauge : Nova Science Publishers, Inc., ©2015
|z 9781634837637
|
| 830 |
|
0 |
|a Horizons in World Cardiovascular Research (NOT ON COVER)
|
| 856 |
4 |
0 |
|u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1100333
|z Texto completo
|
| 938 |
|
|
|a EBSCOhost
|b EBSC
|n 1100333
|
| 938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL4188953
|
| 938 |
|
|
|a YBP Library Services
|b YANK
|n 12759182
|
| 938 |
|
|
|a YBP Library Services
|b YANK
|n 12614437
|
| 994 |
|
|
|a 92
|b IZTAP
|
